GSK - GSK plc

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
14,956,000
14,956,000
4,385,000
5,749,000
4,645,000
Depreciation & amortisation
2,147,000
2,298,000
2,524,000
624,000
2,996,000
Stock-based compensation
346,000
346,000
367,000
381,000
365,000
Change in working capital
270,000
271,000
-473,000
120,000
531,000
Inventory
-269,000
-269,000
25,000
119,000
300,000
Other working capital
5,145,000
5,145,000
5,021,000
6,202,000
5,857,000
Other non-cash items
350,000
803,000
756,000
848,000
814,000
Net cash provided by operating activities
7,403,000
7,403,000
7,952,000
8,441,000
8,020,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,258,000
-2,258,000
-2,931,000
-2,239,000
-2,163,000
Acquisitions, net
-3,374,000
-3,374,000
-294,000
-535,000
-3,953,000
Purchases of investments
-
-
-
-1,000
-258,000
Sales/maturities of investments
1,000
1,000
18,000
3,269,000
1,000
Other investing activities
-3,791,000
-3,791,000
-
-
-
Net cash used for investing activities
-8,772,000
-8,772,000
-1,777,000
2,161,000
-5,354,000
Net change in cash
-546,000
-546,000
-1,414,000
470,000
826,000
Cash at beginning of period
3,819,000
3,819,000
5,262,000
4,831,000
4,087,000
Cash at end of period
3,425,000
3,425,000
3,819,000
5,262,000
4,831,000
Free cash flow
Operating cash flow
7,403,000
7,403,000
7,952,000
8,441,000
8,020,000
Capital expenditure
-2,258,000
-2,258,000
-2,931,000
-2,239,000
-2,163,000
Free cash flow
5,145,000
5,145,000
5,021,000
6,202,000
5,857,000